A day before the Prime Minister of India left for a two-nation tour to Ireland and the United States this September, the National Health Profile 2015 was released by the Minister of Health and Family Welfare Shri JP Nadda. The report, which has presented a dismal picture of the state of public health, shows that cases of cancer is expected to rise in India by almost 15 percent from 11.5...

-The Hindu Business Line A narrow focus on growth-led development is the cause of the world’s sustainability crisis, not its solution The world’s political leaders meet in New York today to adopt a ‘sustainable development’ agenda. On the face of it, this sounds very hopeful. It signals that finally, humanity may move towards making peace with the earth, even as it erases the shame of over two billion people still living in...

-DNA The Centre has always claimed that the country has a robust regulatory mechanism Busting the claims of the Indian government and scientists that the country has a robust regulatory mechanism to test genetically modified (GM) crops, toxic loopholes are emerging. From 2008 to 2014, only 39 of the 133 GM crop field trials were properly monitored, leaving the rest for unknown risks and possible health hazards to common people. Documents accessed...

-The Times of India NEW DELHI: Even as the government is still deliberating on larger pictorial warnings on packs of tobacco products, 40% of Indian adults are exposed to second hand tobacco smoke at home. These are people who do not smoke themselves but are vulnerable to various diseases because someone smokes at home, showed a latest assessment by the World Health Organization, highlighting risks of second hand smoking and the need...

-The Times of India MUMBAI: Certain medicines are being aggressively marketed in India despite inadequate Evidence of safety and efficacy, putting patients at risk, said reputed medical journal Lancet. Highlighting weak regulation and monitoring of the domestic drug industry, three recently-introduced medicines are being prescribed and sold though there is a lack of rigorous trials on crucial safety and efficacy parameters. The pharmaceutical industry in India should face the same stringent regulations...